Cardiac Amyloidosis as a Potential Confounder in Heart Failure With Preserved Ejection Fraction Trials
- PMID: 28774400
- DOI: 10.1016/j.jchf.2017.04.006
Cardiac Amyloidosis as a Potential Confounder in Heart Failure With Preserved Ejection Fraction Trials
Comment on
-
Interaction Between Spironolactone and Natriuretic Peptides in Patients With Heart Failure and Preserved Ejection Fraction: From the TOPCAT Trial.JACC Heart Fail. 2017 Apr;5(4):241-252. doi: 10.1016/j.jchf.2016.11.015. JACC Heart Fail. 2017. PMID: 28359411
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
